Report Overview Global Pet Obesity Management Market reached US$ 1.7 billion in 2023 and is expected to reach US$ 3.1 billion by 2031, growing at a CAGR of 6.8% during the forecast period 2024-2031 Pet obesity management is a growing concern in veterinary care, addressing the global issue of overweight pets. Overfeeding, lack of physical activity, and poor dietary habits are contributing factors. Obesity can lead to health complications like diabetes, heart disease, joint problems, and shorter lifespans. Effective management strategies include nutritional counseling, exercise programs, weight monitoring, and medical interventions. Veterinarians and pet owners collaborate to implement tailored weight loss plans, improving pets' overall health and quality of life. Market Dynamics: Drivers & Restraints Increasing adoption of pets The growing pet population, particularly in urban and suburban areas, is driving the pet obesity management market. This growth is primarily driven by increased demand for healthcare solutions, such as veterinary care, which focuses on maintaining a healthy weight. Pet owners are becoming more aware of the risks of obesity and seek preventive treatments to ensure their pets live long and healthy lives.? The growing awareness of pet health and nutrition is also driving demand for weight management products, specialized diets, and veterinary consultations. The humanization of pets, treating them as part of the family, leads to greater attention to their health and well-being.? For instance, around 6.5 billion animals enter shelters annually, but only 3.2 billion are adopted. With 85 billion families owning pets, the number of animals entering shelters has decreased from over 20 billion in 1973. The Rescue Paw Foundation reports an average 72-hour window for animals to be found and returned. In 2023, people spent $147 billion on their pets, with 96% of Americans reporting a moral duty to protect animals. Approximately 4.1 billion shelter animals are adopted annually, with 2 billion dogs and 2.1 billion cats. Lack of awareness The global pet obesity management market faces challenges such as lack of awareness among pet owners, high costs of specialized diets, limited access to advanced veterinary services, and availability of cheaper, less nutritious pet foods. These factors limit market penetration and highlight the need for greater education, affordability, and access to effective pet obesity solutions to address the growing issue. Market?Segment Analysis The global pet obesity management market is segmented based on product type, animal type, distribution channel, and region. The pet obesity management solutions from the product type segment accounted for approximately 54.3% of the pet obesity management? market share. The pet obesity management solutions from the product type segment accounted for approximately 54.3%. Food supplements are essential in pet obesity management as they provide essential nutrients for healthy weight loss and balanced nutrition. These supplements, including fiber, omega-3 fatty acids, L-carnitine, and other vitamins and minerals, help maintain optimal health during weight loss. Fiber supplements promote satiety, while omega-3 fatty acids support healthy metabolism and reduce inflammation, especially beneficial for overweight pets with joint or mobility issues.? For instance, in November 2023, Calibra, a premium pet food brand by animal health technology company Covetrus, launched its new line of veterinary dog treats in the European Union and Latin America on Nov. 27. Calibra Veterinary Diet Snacks offers a comprehensive range of treats that address common health issues in dogs. Market?Geographical Share North America is estimated to hold about 38.4% of the total market share throughout the forecast period North America is estimated to hold about 38.4% of the total market share throughout the forecast period due to the favorable insurance policies and increased pet owners' concerns about obesity hazards, leading to increased demand for effective weight control programs.? For instance, in August 2024, Akston Biosciences Corporation announced plans to develop a new companion animal obesity drug as part of a new strategic partnership with Energesis Pharmaceuticals, Inc. The partnership intends to manage obesity in companion animals by enhancing their natural ability to burn more calories and increase energy use, promoting healthy weight loss without the potential to rebound. Market Segmentation By Product Food Supplements Drugs Slentrol Yarvitan Others By Animal Type Dogs Cats Others By Distribution Channel Pet specialty stores E-commerce Others? By Region North America U.S. Canada Mexico Europe Germany UK France Italy Spain Rest of Europe South America Brazil Argentina Rest of South America Asia-Pacific China India Japan South Korea Rest of Asia-Pacific Middle East and Africa Market?Competitive Landscape The major global players in the market include Pedigree, Hill's Pet Nutrition, Inc, Pet-AG, Inc., Nestl? Purina, AuxThera, LLC, Blue Buffalo Co., Ltd, Pfizer lnc, ROYAL CANIN SAS, Vivaldis among others. Key Developments In March 2023, Sun Pharmaceutical Industries Limited signed an agreement to purchase a 60% stake in Vivaldis Health and Foods Private Limited. Vivaldis Health & Foods operates in the companion animal healthcare industry, focusing on trading, distributing, manufacturing, and marketing drugs, food supplements, and OTC products. Why Purchase the Report? To visualize the global pet obesity management market segmentation based on product type, animal type, distribution channel, and region as well as understand key commercial assets and players. Identify commercial opportunities by analyzing trends and co-development.? Excel data sheet with numerous data points of the pet obesity management market level with all segments. PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study. Product mapping available as excel consisting of key products of all the major players. The global pet obesity management market report would provide approximately 64 tables, 61 figures, and 186 pages. Target Audience 2024 Manufacturers/ Buyers Industry Investors/Investment Bankers Research Professionals Emerging Companies